Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
Simona Caporali(Istituto Dermopatico dell'Immacolata), Stefania D’Atri(Istituto Dermopatico dell'Immacolata)
Cited by 72
Related Papers
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
|Journal of Experimental & Clinical Cancer Research|2019|84
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
|Journal of Translational Medicine|2012|39